2021.03.18 Press release

--To the press -

FRONTEO signs a contract to use the paper search AI system "Amanogawa" with the field of advanced engineering surgery, Tokyo Women's Medical University Institute of Advanced Biomedical Sciences

FRONTEO Inc.
Masahiro Morimoto, President and CEO
東京 都 港区 港 南 2-12-23
(Code number: 2158 TSE Mothers)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) is a field of advanced engineering and foreign science at the Institute of Advanced Biomedical Sciences, Tokyo Womens Medical University (Location: Shinjuku-ku, Tokyo, Representative: Village). We have signed a contract with Yoshihiro Kaki (FATS) for the academic plan for educational and research institutes of the paper search AI system "Amanogawa (patent / trademark pending)".

 

 FATS was established at Tokyo Women's Medical University with the aim of promoting research and education in advanced medicine based on the fusion of medicine, science and technology, and industry-academia.It is characterized by the fact that researchers with various specialties such as medical and engineering belong to it, utilizing IoT, AI, robots such as intelligent operating rooms, smart treatment rooms, real-time navigation systems and surgical robots. We are conducting research and development of medical equipment.

 

 When researchers from diverse backgrounds collaborate, even if they are synonymous, they often handle different expressions and terms, and it may be difficult to reach the desired search results by keyword search alone.Amanogawa, on the other hand, features a search for concepts, allowing you to search for treatises without being affected by differences in expressions or terms depending on your specialty.Amanogawa has been evaluated as suitable for medical device research, which is currently being jointly undertaken by FATS and the Department of Neonatal Science, Tokyo Women's Medical University, and has been introduced this time.This is the first case of using Amanogawa for research in the medical device field.

 

 FRONTEO will continue to focus on research and development so that it can contribute to the development of medicine and the medical industry by providing AI systems such as Amanogawa.

 

Amanogawa  URL: https://lifescience.fronteo.com/aidiscovery/amanogawa/

"Amanogawa (trademark / patent pending)" is a paper search AI system equipped with FRONTEO's original AI engine "Concept Encoder (registered trademark: concept encoder, reading: concept encoder)".When a researcher inputs a sentence such as a word or hypothesis of interest, "Concept Encoder" instantly detects the article related to the input content from the large number of articles published in PubMed *.

Since the search results are plotted in a map according to the similarity between the articles, you can check the relevance at a glance, and drag the article information detected on the map to narrow down the search, which is a visual that has never been seen before. You can search for articles.In addition, you can sort the search results in order of relevance and list their abstracts, greatly streamlining your article search.This makes it possible to discover events and new drug targets from a perspective that is difficult for humans to notice.

* PubMed: A database that allows you to search for articles in the field of biomedical science.Created by the National Center for Biological Sciences in the National Library of Medicine.

 

■ About Concept Encoder URL:https://lifescience.fronteo.com/technology/conceptencoder/

"Concept Encoder (registered trademark: concept encoder, reading: concept encoder)" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. "Concept Encoder" can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vital signs and various test values ​​accumulated in the life science field. ..Patent registration number: Patent No. 6346367

 

Tokyo Women's Medical University Institute for Advanced Biomedical Sciences Advanced Engineering Department of Surgery URL:https://www.twmu.ac.jp/ABMES/FATS/

The Faculty of Advanced Techno Surgery (FATS) is a research organization founded by Professor Kimitomo Takakura and Professor Hiroshi Izeki with the opening of the Department of Advanced Biomedical Sciences, Graduate School of Medicine in April 2001. ..Currently, the laboratory members, led by Professor Yoshihiro Muragaki and Professor Ken Masamune, are medical professionals (doctors, pharmacists, etc.) and engineers (robot engineering, information science and engineering, etc.) We carry out industry-government-academia collaboration with students.Through research and development of intelligent operating rooms centered on intraoperative MRI, smart treatment rooms, real-time navigation systems, and surgical robots, we aim to realize information-guided surgery and precision-guided treatment that can predict the future.

 

FRONTEO URL: https://www.fronteo.com/

FRONTEO uses the in-house developed AI engine "KIBIT" and "concept encoder" specializing in natural language processing to extract meaningful and important information from a huge amount of text data to support corporate business. A data analysis company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support international litigation of companies. Has been deployed.Based on the AI ​​technology cultivated in the legal tech business, we expanded the business field to the life science field, business intelligence field, and OSINT from 8, and created by using AI to "turn text data into knowledge". We contribute to solving various corporate issues such as drug support, dementia diagnosis support, financial, human resources, and sales support. Listed on TSE Mothers on June 2014, 2007. January 6, 26 Obtained a first-class medical device manufacturing and sales license (permit number: 2021B1X13).The capital is 13 thousand yen (as of March 1, 10350).

 

* FRONTEO, KIBIT, and concept encoder are registered trademarks of FRONTEO in Japan.

<Contact information for the press>

Public Relations Officer, FRONTEO Inc. Segawa

E-mail: pr_contact@fronteo.com

 

<Inquiries about Life Science AI Business>

FRONTEO Inc. Life Science AI Business Headquarters

https://lifescience.fronteo.com/contact

ja 日本語
Machine Translation by Google. : close x